R5 Pharmaceuticals Overview

  • Founded
  • 2006
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 15
Employees
  • Latest Deal Type
  • M&A

R5 Pharmaceuticals General Information

Description

Developer of medicines and clinical trial materials. The company develops and manufactures medicines and materials for phase 1 and phase 2 clinical trials.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • BioCity Nottingham
  • Pennyfoot Street,
  • Nottingham NG1 1GF
  • England, United Kingdom
+44 0115 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

R5 Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Jul-2010 00000 Completed Product Development
1. Early Stage VC 04-Apr-2007 00000 00000 Completed Product Development
To view R5 Pharmaceuticals’s complete valuation and funding history, request access »

R5 Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of medicines and clinical trial materials. The company develops and manufactures medicines and materials for p
Drug Discovery
Nottingham, United Kingdom
15 As of 2016
00000
000000&0 00000

000000

amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua
00000 0000000000 00000000
Clearwater, FL
000 As of 0000
0000
000000000000 0000

0000000

s nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
000000000000000
Loures, Portugal
0000 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

R5 Pharmaceuticals Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CoreRx Private Equity-Backed Clearwater, FL 000 0000 000000000000 0000
0000000 Corporation Loures, Portugal 0000
0000000 Private Equity-Backed East Rutherford, NJ 0000 000000000000
000000 Private Equity-Backed Wilmington, NC 000 00.00 000000000 00
0000000 0000000000 Formerly VC-backed Heidelberg, Germany 000 00000 000000000 00000
You’re viewing 5 of 10 competitors. Get the full list »

R5 Pharmaceuticals Executive Team (1)

Name Title Board Seat Contact Info
Paul Titley Chief Executive Officer
To view R5 Pharmaceuticals’s complete executive team members history, request access »

R5 Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

R5 Pharmaceuticals Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BioCity Accelerator/Incubator Minority 000 0000 000000 0
Catapult Ventures Venture Capital Minority 000 0000 000000 0
Mobius Life Sciences Fund Venture Capital Minority 000 0000 000000 0
To view R5 Pharmaceuticals’s complete investors history, request access »